<!-- received="Tue Sep 21 12:45:29 1999 MDT" -->
<!-- sent="Tue, 21 Sep 1999 11:42:26 -0700" -->
<!-- name="Jeff Davis" -->
<!-- email="jdavis@socketscience.com" -->
<!-- subject="fwd: cryosuspension progress--21CM patent" -->
<!-- id="3.0.6.32.19990921114226.007af9a0@coastside.net" -->
<!-- inreplyto="" -->
<!-- version=1.10, linesinbody=78 -->
<html><head><title>extropians: fwd: cryosuspension progress--21CM patent</title>
<meta name=author content="Jeff Davis">
<link rel=author rev=made href="mailto:jdavis@socketscience.com" title ="Jeff Davis">
</head><body>
<h1>fwd: cryosuspension progress--21CM patent</h1>
Jeff Davis (<i>jdavis@socketscience.com</i>)<br>
<i>Tue, 21 Sep 1999 11:42:26 -0700</i>
<p>
<ul>
<li> <b>Messages sorted by:</b> <a href="date.html#4604">[ date ]</a><a href="index.html#4604">[ thread ]</a><a href="subject.html#4604">[ subject ]</a><a href="author.html#4604">[ author ]</a>
<!-- next="start" -->
<li><a href="4605.html">[ Next ]</a><a href="4603.html">[ Previous ]</a>
<!-- nextthread="start" -->
<b>Next in thread:</b> <a href="4609.html">Eugene Leitl</a>
</ul>
<!-- body="start" -->

<p>
<a name="4609qlink1"><i>&gt;From the cryonet:</i><br>

<p>
<i>&gt;Message #12443</i><br>
<a name="5121qlink1"><i>&gt;From: Ettinger@aol.com</i><br>
<i>&gt;Date: Mon, 20 Sep 1999 14:08:22 EDT</i><br>
<i>&gt;Subject: 21CM</a> patent</i><br>
</a>
<i>&gt;</i><br>
<a name="5121qlink2"><i>&gt;Go to www.uspto.gov to access the full text of the patent (Sep.14)</a> assigned </i><br>
<a name="5121qlink3"><i>&gt;to 21st Century Medicine Inc. Oddly enough, the inventors listed do not </i><br>
<i>&gt;include Greg Fahy; they are Brian G. Wowk, Michael G.</a> Federowicz ["Darwin"], </i><br>
<a name="5121qlink4"><i>&gt;Sandra R. Russell, and Steven B. Harris. It runs about 18 printed pages.</a></i><br>
<i>&gt;</i><br>
<a name="5121qlink5"><i>&gt;Naturally, we will investigate the procedures and substances mentioned.</a></i><br>
<i>&gt;</i><br>
<a name="5121qlink6"><i>&gt;There are many interesting features in the patent, not least</a> the structure</i><br>
of 
<br>
<a name="5121qlink7"><i>&gt;claims. The claims start broadly, including any alkoxylated</a> organic compound </i><br>
<a name="5121qlink8"><i>&gt;in a concentration sufficient to permit vitrification and cooling until </i><br>
<i>&gt;vitrified; and the application of this to any organ, tissue, or animal.</a> More </i><br>
<a name="5121qlink9"><i>&gt;specific claims relate to use of 2-methoxyethanol and </i><br>
<i>&gt;3-methoxy-1,2-propanediol.</a></i><br>
<i>&gt;</i><br>
<a name="5121qlink10"><i>&gt;The inventors acknowledge that glycol ethers have been used before to </i><br>
<i>&gt;preserve embryos and cell suspensions, but believe they have priority in </i><br>
<i>&gt;application to tissues, organs, and animals. Obviously, there</a> are</i><br>
potentially 
<br>
<a name="5121qlink11"><i>&gt;interesting questions in patent law--both as to the relation between</a> these </i><br>
<a name="5121qlink12"><i>&gt;inventors and prior users of glycol ethers, and between these</a> inventors and </i><br>
<a name="5121qlink13"><i>&gt;later users of new variations and applications.</a></i><br>
<i>&gt;</i><br>
<i>&gt;"Summary" of the invention mentions perfusing an inert fluid through the </i><br>
<i>&gt;vascular system and controlling the temperature of the fluid; and a class of </i><br>
<i>&gt;new glycol ether CPAs. Oddly enough, the Claims do not (to my legally </i><br>
<i>&gt;untutored mind) appear to make any direct or specific reference to cooling </i><br>
<i>&gt;methods, even though in the "Summary" that seems important.</i><br>
<i>&gt;</i><br>
<a name="5121qlink14"><i>&gt;"Glycol ethers" are understood to include compounds containing alkoxy--</a>and </i><br>
<a name="5121qlink15"><i>&gt;particularly methoxy--functional groups. Included are alkoxylated</a> alkanes</i><br>
and 
<br>
<a name="5121qlink16"><i>&gt; alkoxylated alcohols and polyols, with several sub-groups given.</a></i><br>
<i>&gt;</i><br>
<a name="5121qlink17"><i>&gt;For some organs, cooling and rewarming rates can exceed 100 degC</a> per minute. </i><br>
<a name="5121qlink18"><i>&gt;[This seems to suggest possible use with other CPAs, such as amides.]</a></i><br>
<i>&gt;</i><br>
<a name="5121qlink19"><i>&gt;"Large animals can be perfused wit high concentrations of  glycol</a> ethers</i><br>
near 
<br>
<a name="5121qlink20"><i>&gt;0 C with rapid equilibration, no dehydration, no edema or other visible </i><br>
<i>&gt;evidence of toxic effects. Histologic preservation is excellent at </i><br>
<i>&gt;microscopic and ultrasturctural levels."</a> </i><br>
<i>&gt;</i><br>
<a name="5121qlink21"><i>&gt;References include Skrecky's proposal in Cryonet #5174, 1995; CRYONICS: </i><br>
<i>&gt;REACHING FOR TOMORROW (Wowk &amp; Darwin, 1991; and THE PROSPECT OF IMMORTALITY, </i><br>
</a>
<a name="5121qlink22"><i>&gt;1964; and a Darwin/Hixon piece in CRYONICS July 1984, as well as various </i><br>
<i>&gt;patents and publications in recognized journals.</a></i><br>
<i>&gt;</i><br>
<a name="5121qlink23"><i>&gt;I have not found any patent entries under "ice blockers," although the </i><br>
<i>&gt;instant patent says that suppression of ice formation is an important </i><br>
<i>&gt;feature. I believe 21CM has a different class of substances it calls ice </i><br>
<a name="5121qlink29"><a name="5046qlink1"><i>&gt;blockers, acting through a different mechanism.</a></a></a></i><br>
<i>&gt;</i><br>
<a name="5121qlink24"><i>&gt;The "Conclusion" mentions unprecedentedly high rates of cooling and </i><br>
<i>&gt;rewarming,;and the advantages of the new CPAs, including penetration</a> and low </i><br>
<a name="5121qlink25"><i>&gt;viscosity, rapid equilibration, ice inhibition, minimization of toxicity,</a></i><br>
and 
<br>
<a name="5121qlink26"><i>&gt;glass forming properties.</a>  </i><br>
<i>&gt;</i><br>
<a name="5121qlink27"><i>&gt;Congratulations to all the inventors involved. Lots of work ahead.</a></i><br>
<i>&gt;</i><br>
<i>&gt;Robert Ettinger</i><br>
<i>&gt;Cryonics Institute</i><br>
<i>&gt;Immortalist Society</i><br>
<a name="5121qlink28"><i>&gt;<a href="http://www.cryonics.</a>org">http://www.cryonics.org</a> </i><br>
<i>&gt;</i><br>
<p>
			Best, Jeff Davis

<pre>
	   "Everything's hard till you know how to do it."
					Ray Charles				
</pre>
<!-- body="end" -->
<p>
<ul>
<!-- next="start" -->
<li><a href="4605.html">[ Next ]</a><a href="4603.html">[ Previous ]</a>
<!-- nextthread="start" -->
<b>Next in thread:</b> <a href="4609.html">Eugene Leitl</a>
</ul>
</body></html>
